• Viewpoint

Helping Chemical and Pharmaceutical clients to grow in Asia

Chemical & Pharmaceutical Capability in Asia

Matthias Boos

Sector Leader - Chemical & Pharmaceutical, Asia +86 21 6026 1300 Ask me a question

Whilst sales of generic medicines are booming in the emerging markets like China, India and Singapore, research-focused bio-pharmaceutical companies are investing in their R&D programs to try and produce a small volume of breakthrough products that will shape the future of the pharmaceuticals market.

Similarly,  within the Chemicals sector it indicates that 2/3 of total global demand for Chemicals will come from within Asia.

As a result, to drive greater success of their investment and to deliver increasing shareholder value, multi-nationals will need a strategy and the necessary governance in place to minimize risks, ensure the high quality of delivery and a higher capital return.

Questions about this article

Matthias Boos

Sector Leader - Chemical & Pharmaceutical, Asia +86 21 6026 1300 Ask me a question

Arcadis White paper

Chemical & Pharmaceutical Capability in Asia

Helping Chemical & Pharmaceutical Clients Grow in Asia